# Examining neuroimaging biomarkers, plasma biomarkers and cognitive functions in patients with recovered COVID-19 infection: a multicentre study using 7T MRI

**Authors:** Jr-Jiun Liou, Tales Santini, Jinghang Li, Monica Gireud-Goss, Tiffany F Kautz, Julie Parker-Garza, Juan Carlos Guerrero, Vibhuti Patel, Oluwatobi F Adeyemi, Gabriel A de Erausquin, Valentina R Garbarino, Mohamad Habes, Jayandra J Himali, Christof Karmonik, Beth E Snitz, Joseph M Mettenburg, Minjie Wu, Howard J Aizenstein, Anna L Marsland, Peter J Gianaros, Richard Bowtell, Olivier Mougin, Penny A Gowland, Mohammad Zia Katshu, Farhaan S Vahidy, Timothy D Girard, Heidi I L Jacobs, Akram A Hosseini, Sudha Seshadri, Tamer S Ibrahim, Sudha Seshadri, Sudha Seshadri, Farhaan S Vahidy, Timothy D Girard, Heidi I L Jacobs, Akram A Hosseini, Tamer S Ibrahim

PMC · DOI: 10.1093/braincomms/fcag045 · Brain Communications · 2026-03-09

## TL;DR

This study found that hospitalized COVID-19 patients had lower hippocampal volume and worse memory compared to non-hospitalized individuals, but similar brain white matter changes.

## Contribution

The study is the first to use 7T MRI to examine neuroimaging and plasma biomarkers in recovered hospitalized and non-hospitalized COVID-19 patients.

## Key findings

- Hospitalized patients had lower hippocampal volume and poorer memory than non-hospitalized controls.
- Higher white matter hyperintensity burden was linked to worse cognition and higher plasma biomarker levels.
- Biomarker–cognition correlations were similar between hospitalized and non-hospitalized groups.

## Abstract

We examined the impact of COVID-19 hospitalization on neuroimaging biomarkers and the association of these neuroimaging biomarkers with cognitive measures and plasma biomarkers. A total of 179 dementia-free people, including 52 hospitalized COVID-19 patients, across four medical centres in the USA and UK underwent 7T brain MRI scans, cognitive tests and blood collection. We found that hospitalized patients exhibited a comparable white matter hyperintensity burden, lower total hippocampal volume and lower plasma glial fibrillary acidic protein concentration, along with poorer memory performance, compared to age-matched non-hospitalized participants. Higher white matter hyperintensity burden was associated with older age, worse cognitive scores and higher plasma biomarker levels; higher total hippocampal volume was associated with younger age, better cognitive scores and lower plasma phosphorylated tau levels. However, these correlation coefficients did not differ between the hospitalized and non-hospitalized groups. Longitudinal studies are needed to clarify the long-term impact of COVID-19-related hospitalization.

Liou et al. found hospitalized COVID-19 patients had lower hippocampal volume, reduced plasma glial fibrillary acidic protein and poorer memory than age-matched controls, despite similar white matter hyperintensity burden. Biomarker–cognition correlations aligned with age and did not differ by hospitalization status. Longitudinal studies need to clarify the long-term impacts of COVID-19-related hospitalization.

Graphical AbstractFor image description, please refer to the figure legend and surrounding text.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** CA2 (carbonic anhydrase 2) [NCBI Gene 760] {aka CA-II, CAC, CAII, Car2, HEL-76, HEL-S-282}, CA1 (carbonic anhydrase 1) [NCBI Gene 759] {aka CA-I, CAB, Car1, HEL-S-11}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, NEFL (neurofilament light chain) [NCBI Gene 4747] {aka CMT1F, CMT2E, CMTDIG, NF-L, NF68, NFL}, CA3 (carbonic anhydrase 3) [NCBI Gene 761] {aka CAIII, Car3}, GFAP (glial fibrillary acidic protein) [NCBI Gene 2670] {aka ALXDRD}
- **Diseases:** head injury (MESH:D006259), influenza (MESH:D007251), Alzheimer's and Neurodegenerative Diseases (MESH:D019636), critical illness (MESH:D016638), hippocampal atrophy (MESH:D001284), Alzheimer (MESH:D000544), brain atrophy (MESH:C566985), diabetes (MESH:D003920), cancer (MESH:D009369), B12 deficiency (MESH:D014806), acute ischaemic stroke (MESH:D020521), pneumonia (MESH:D011014), WMH (MESH:D056784), multiorgan dysfunction (MESH:D009102), obesity (MESH:D009765), hypoxic injury (MESH:D002534), acute infection (MESH:D000208), hypertension (MESH:D006973), injuries in the brain (MESH:D001930), neurological damage (MESH:D020196), brain damage (MESH:D001925), intracranial haemorrhage (MESH:D013345), viral infection (MESH:D014777), smell loss (MESH:D000086582), myocardial infarction (MESH:D009203), infection (MESH:D007239), cardiovascular (MESH:D002318), COVID (MESH:D000086382), atrial fibrillation (MESH:D001281), Dementia (MESH:D003704), thyroid disease (MESH:D013959), congestive heart failure (MESH:D006333), cognitive decline (MESH:D003072), neuropathological (MESH:D009422), sepsis (MESH:D018805), long COVID-19 (MESH:D000094024), memory deficits (MESH:D008569), migraine (MESH:D008881), sleep apnoea (MESH:D012891)
- **Chemicals:** oxygen (MESH:D010100), hydrocortisone (MESH:D006854), EDTA (MESH:D004492), benzodiazepine (MESH:D001569), IL6 receptor antagonists (-), NO (MESH:D009614), alcohol (MESH:D000438), heparin (MESH:D006493)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967851/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967851/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967851/full.md

---
Source: https://tomesphere.com/paper/PMC12967851